Outcome of Board Meeting Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Company Update Pursuant to Regulation 32 of SEBI, Regulations,2015, please find enclosed the statement of Deviation or Variation in utilization of funds raised through Preferential issue of Equity Shares by the company. Pursuant to Regulation 32 of SEBI, Regulations,2015, please find enclosed the statement of Deviation or Variation in utilization of funds raised through Preferential issue of Equity Shares by the company.
Company Update Pursuant to Regulation 32 of SEBI, Regulations,2015, please find enclosed the statement of Deviation or Variation in utilization of funds raised through Preferential issue of Equity Shares by the company. Pursuant to Regulation 32 of SEBI, Regulations,2015, please find enclosed the statement of Deviation or Variation in utilization of funds raised through Preferential issue of Equity Shares by the company.
Outcome of Board Meeting Regency Ceramics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Regency Ceramics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Regency Ceramics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Regency Ceramics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Board Meeting Outcome of Board Meeting under Regulations 30 and 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: 1. Audited Financial Results (Standalone & Consolidated) for the year ended March 31, 2026 along with the Statutory Auditors'' Reports on the Standalone and Consolidated Financial Results for the financial year ended March 31, 2026 and the Declaration regarding Unmodified Opinion pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015.
Board Meeting Outcome of Board Meeting under Regulations 30 and 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: 1. Audited Financial Results (Standalone & Consolidated) for the year ended March 31, 2026 along with the Statutory Auditors'' Reports on the Standalone and Consolidated Financial Results for the financial year ended March 31, 2026 and the Declaration regarding Unmodified Opinion pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015.
General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru
General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru
Corp. Action The board recommended the payment of final dividend of Rs 0.80 (8%) per equity share of face value of Rs 10/- each for the financial year 2025-26. Record date has been fixed as Tuesday, the 15th September, 2026 The board recommended the payment of final dividend of Rs 0.80 (8%) per equity share of face value of Rs 10/- each for the financial year 2025-26. Record date has been fixed as Tuesday, the 15th September, 2026
Corp. Action The board recommended the payment of final dividend of Rs 0.80 (8%) per equity share of face value of Rs 10/- each for the financial year 2025-26. Record date has been fixed as Tuesday, the 15th September, 2026 The board recommended the payment of final dividend of Rs 0.80 (8%) per equity share of face value of Rs 10/- each for the financial year 2025-26. Record date has been fixed as Tuesday, the 15th September, 2026
Corp Action Board had recommended dividend @ 10% on face value, subjec to approval of shareholders. Board Proposed to conducted AGM on 26th September, 2026 Board had recommended dividend @ 10% on face value, subjec to approval of shareholders. Board Proposed to conducted AGM on 26th September, 2026
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.